Search
Close this search box.

Malena Spar

Junior Investigators Selected for Intensive in Deprescribing Research!

We are very pleased to announce our 2020-2021 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning opportunities to help fellows, post-docs, and early-stage faculty succeed with their deprescribing-related research and advance their research careers. Our inaugural cohort awardees include 15 outstanding physician, pharmacist, and nurse investigators […]

Junior Investigators Selected for Intensive in Deprescribing Research! Read More »

Two new AD/ADRD-related RFAs from the IMPACT Collaboratory

The IMPACT Collaboratory released two new Requests for Applications (RFAs) for conducting pragmatic trials in persons with AD/ADRD on April 20: Request for Applications for 1-year ePCT pilot studies for up to $175,000 (direct costs) In response to the coronavirus disease (COVID-2019) outbreak, in this award cycle, the IMPACT Collaboratory will prioritize applications proposing pilot

Two new AD/ADRD-related RFAs from the IMPACT Collaboratory Read More »

COVID-19 response in post-acute and long-term care: Task force develops new guide to optimize medications.

A task force convened by the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland School of Pharmacy with assistance from the US Deprescribing Research Network has released a new implementation guide to optimize medications. Its goal is to improve resident-centered health and well-being by reducing use of unnecessary medications, simplifying

COVID-19 response in post-acute and long-term care: Task force develops new guide to optimize medications. Read More »

A new review article says it’s time to refine current adverse drug event adjudication methods to fit deprescribing studies.

Ross S, et al. Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16382 A recent review article published in the Journal of the American Geriatrics Society examined adverse drug event (ADE) adjudication methods in deprescribing studies. Ross and colleagues of McGill University in Montreal,

A new review article says it’s time to refine current adverse drug event adjudication methods to fit deprescribing studies. Read More »

Eliminating Medication Overload: A National Action Plan from the Lown Institute

Medication overload is an epidemic among older Americans. Every day, 750 Americans age 65 and over are hospitalized for a side effect caused by one more medications.   To eliminate medication overload, significant cultural, educational, and policy changes are needed. The Lown Institute has just released Eliminating Medication Overload: A National Action Plan, with recommendations for

Eliminating Medication Overload: A National Action Plan from the Lown Institute Read More »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.